Reversal of cyclic AMP-mediated intestinal secretion in mice by chlorpromazine
- PMID: 213346
Item in Clipboard
Reversal of cyclic AMP-mediated intestinal secretion in mice by chlorpromazine
Gastroenterology.
1978 Dec.
No abstract available
Similar articles
-
A new principle for resistance to cholera: desensitization to cyclic AMP-mediated diarrhea induced by cholera toxin in the mouse intestine.J Cyclic Nucleotide Res. 1981;7(4):247-57. J Cyclic Nucleotide Res. 1981. PMID: 6278008
-
Chlorpromazine inhibits cholera toxin-induced intestinal hypersecretion.Med Biol. 1977 Jun;55(3):126-9. Med Biol. 1977. PMID: 197323
-
Intestinal secretion.Int Rev Physiol. 1977;12:257-84. Int Rev Physiol. 1977. PMID: 190182 Review. No abstract available.
-
Propranolol prevention of cholera enterotoxin-induced intestinal secretion in the rat.Gastroenterology. 1979 Mar;76(3):482-91. Gastroenterology. 1979. PMID: 218865 No abstract available.
-
Cyclic nucleotides and their role in gastrointestinal secretion.Gastroenterology. 1974 Nov;67(5):1023-64. Gastroenterology. 1974. PMID: 4154262 Review. No abstract available.
Cited by
-
Treatment of infectious diarrhea in children.Paediatr Drugs. 2003;5(3):151-65. doi: 10.2165/00128072-200305030-00002. Paediatr Drugs. 2003. PMID: 12608880 Review.
-
Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins.Infect Immun. 1982 Feb;35(2):471-5. doi: 10.1128/iai.35.2.471-475.1982. Infect Immun. 1982. PMID: 7035365 Free PMC article.
-
Efficacy and tolerability of racecadotril in the treatment of cholera in adults: a double blind, randomised, controlled clinical trial.Gut. 2003 Oct;52(10):1419-23. doi: 10.1136/gut.52.10.1419. Gut. 2003. PMID: 12970133 Free PMC article. Clinical Trial.
-
Inhibition of Escherichia coli heat-stable enterotoxin by indomethacin and chlorpromazine.Infect Immun. 1980 Sep;29(3):908-13. doi: 10.1128/iai.29.3.908-913.1980. Infect Immun. 1980. PMID: 6107277 Free PMC article.
-
Differentiation of secretagogue drugs by chlorpromazine in rat intestine in vivo.Naunyn Schmiedebergs Arch Pharmacol. 1983 Sep;324(1):70-4. doi: 10.1007/BF00647841. Naunyn Schmiedebergs Arch Pharmacol. 1983. PMID: 6688858